Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

Abstract

The growth arrest-specific gene 6 product (Gas6) is a secreted protein related to the anticoagulant protein S but its role in hemostasis is unknown. Here we show that inactivation of the Gas6 gene prevented venous and arterial thrombosis in mice, and protected against fatal collagen/epinephrine-induced thrombo embolism. Gas6−/− mice did not, however, suffer spontaneous bleeding and had normal bleeding after tail clipping. In addition, we found that Gas6 antibodies inhibited platelet aggregation in vitro and protected mice against fatal thrombo embolism without causing bleeding in vivo. Gas6 amplified platelet aggregation and secretion in response to known agonists. Platelet dysfunction in Gas6−/− mice resembled that of patients with platelet signaling transduction defects. Thus, Gas6 is a platelet-response amplifier that plays a significant role in thrombosis. These findings warrant further evaluation of the possible therapeutic use of Gas6 inhibition for prevention of thrombosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Targeting of the Gas6 gene.
Figure 5: Expression and role of Gas6 in platelets.
Figure 2: Inactivation or inhibition of Gas6 protects mice against thrombosis.
Figure 3: Effect of Gas6 deficiency or of anti-Gas6 antibodies on platelet aggregation.
Figure 4: Role of Gas6 in the formation of platelet macro-aggregates.

Similar content being viewed by others

References

  1. Schneider, C., King, R.M. & Philipson, L. Genes specifically expressed at growth arrest of mammalian cells. Cell 54, 787–793 (1988).

    Article  CAS  Google Scholar 

  2. Manfioletti, G., Brancolini, C., Avanzi, G. & Schneider, C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol. 13, 4976–4985 (1993).

    Article  CAS  Google Scholar 

  3. Dahlback, B. Blood coagulation. Lancet 355, 1627–1632 (2000).

    Article  CAS  Google Scholar 

  4. Dahlback, B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb. Haemost. 66, 49–61 (1991).

    Article  CAS  Google Scholar 

  5. Borgel, D., Gandrille, S. & Aiach, M. Protein S deficiency. Thromb. Haemost. 78, 351–356 (1997).

    Article  CAS  Google Scholar 

  6. Nakano, T. et al. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272, 29411–29414 (1997).

    Article  CAS  Google Scholar 

  7. Varnum, B.C. et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 373, 623–626 (1995).

    Article  CAS  Google Scholar 

  8. Godowski, P.J. et al. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 82, 355–358 (1995).

    Article  CAS  Google Scholar 

  9. Nagata, K. et al. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J. Biol. Chem. 271, 30022–30027 (1996).

    Article  CAS  Google Scholar 

  10. Crosier, K.E. & Crosier, P.S. New insights into the control of cell growth; the role of the AxI family. Pathology 29, 131–135 (1997).

    Article  CAS  Google Scholar 

  11. Chen, J., Carey, K. & Godowski, P.J. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 14, 2033–2039 (1997).

    Article  CAS  Google Scholar 

  12. Goruppi, S., Ruaro, E. & Schneider, C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12, 471–80 (1996).

    CAS  PubMed  Google Scholar 

  13. Li, R. et al. Identification of Gas6 as a growth factor for human Schwann cells. J. Neurosci. 16, 2012–2019 (1996).

    Article  CAS  Google Scholar 

  14. Nakano, T. et al. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J. Biol. Chem. 270, 5702–5705 (1995).

    Article  CAS  Google Scholar 

  15. Fridell, Y.W., Villa, J., Jr., Attar, E.C. & Liu, E.T. GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J. Biol. Chem. 273, 7123–7126 (1998).

    Article  CAS  Google Scholar 

  16. McCloskey, P. et al. GAS6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J. Biol. Chem. 272, 23285–23291 (1997).

    Article  CAS  Google Scholar 

  17. Lu, Q. et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 398, 723–728 (1999).

    Article  CAS  Google Scholar 

  18. Rao, A.K. & Gabbeta, J. Congenital disorders of platelet signal transduction. Arterioscler. Thromb. Vasc. Biol. 20, 285–289 (2000).

    Article  CAS  Google Scholar 

  19. Herbert, J.M., Bernat, A. & Maffrand, J.P. Importance of platelets in experimental venous thrombosis in the rat. Blood 80, 2281–2286 (1992).

    CAS  PubMed  Google Scholar 

  20. Matsuno, H. et al. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator. Br. J. Pharmacol. 106, 533–538 (1992).

    Article  CAS  Google Scholar 

  21. Evenas, P., Garcia de Frutos, P., Nicolaes, G.A. & Dahlback, B. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thromb. Haemost. 84, 271–277 (2000).

    Article  CAS  Google Scholar 

  22. Offermanns, S., Toombs, C.F., Hu, Y.H. & Simon, M.I. Defective platelet activation in G α(q)-deficient mice. Nature 389, 183–186 (1997).

    Article  CAS  Google Scholar 

  23. Bennett, J.S. Integrin structure and function in hemostasis and thrombosis. Ann. NY Acad. Sci. 614, 214–228 (1991).

    Article  CAS  Google Scholar 

  24. Avanzi, G.C. et al. GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity. Exp. Hematol. 25, 1219–1226 (1997).

    CAS  PubMed  Google Scholar 

  25. Ishimoto, Y. & Nakano, T. Release of a product of growth arrest-specific gene 6 from rat platelets. FEBS Lett. 466, 197–199 (2000).

    Article  CAS  Google Scholar 

  26. Marcus, A.J. Platelets and their disorders. in Disorders of Hemostasis (eds. Ratnoff, O.D. & Forbes, C.D.) 79–137 (W.B. Sauders, Philadelphia, Pennsylvania, 1996).

    Google Scholar 

  27. Mark, M.R., Chen, J., Hammonds, R.G., Sadick, M. & Godowsk, P.J. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J. Biol. Chem. 271, 9785–9789 (1996).

    Article  CAS  Google Scholar 

  28. DiMinno, G. & Silver, M.J. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J. Pharmacol. Exp. Ther. 225, 57–60 (1983).

    CAS  PubMed  Google Scholar 

  29. Neubauer, A. et al. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood 84, 1931–1941 (1994).

    CAS  PubMed  Google Scholar 

  30. O'Donnell, K., Harkes, I.C., Dougherty, L. & Wicks, I.P. Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am. J. Pathol. 154, 1171–1180 (1999).

    Article  CAS  Google Scholar 

  31. Gabbeta, J. et al. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation. Blood 87, 1368–76 (1996).

    CAS  PubMed  Google Scholar 

  32. Fabre, J.E. et al. Decreased platelet aggregation, increased bleeding time and resistance to thrombo embolism in P2Y1-deficient mice. Nature Med. 5, 1199–1202 (1999).

    Article  CAS  Google Scholar 

  33. Leon, C. et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest. 104, 1731–1737 (1999).

    Article  CAS  Google Scholar 

  34. Carmeliet, P. et al. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J. Clin. Invest. 92, 2746–2755 (1993).

    Article  CAS  Google Scholar 

  35. Vogel, G.M., Meuleman, D.G., Bourgondien, F.G. & Hobbelen, P.M. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. Thromb. Res. 54, 399–410 (1989).

    Article  CAS  Google Scholar 

  36. Umemura, K., Nishiyama, H., Kikuchi, S., Kondo, K. & Nakashima, M. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery. Thromb. Haemost. 76, 799–806 (1996).

    Article  Google Scholar 

  37. Kawasaki, T., Kaida, T., Arnout, J., Vermylen, J. & Hoylaerts, M.F. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb. Haemost. 81, 306–3011 (1999).

    Article  CAS  Google Scholar 

  38. Stassen, J.M., Vanlinthout, I., Lijnen, H.R. & Collen, D. A hamster pulmonary embolism model for the evaluation of the thrombolytic and pharmacokinetic properties of thrombolytic agents. Fibrinolysis 4, Supp., 15–21 (1990).

    Article  CAS  Google Scholar 

  39. Dejana, E., Callioni, A., Quintana, A. & de Gaetano, G. Bleeding time in laboratory animals. II - A comparison of different assay conditions in rats. Thromb. Res. 15, 191–197 (1979).

    Article  CAS  Google Scholar 

  40. Grinnell, B.W. et al. γ-carboxylated isoforms of recombinant human protein S with different biologic properties. Blood 76, 2546–2554 (1990).

    CAS  PubMed  Google Scholar 

  41. Yan, S.B. Review of conformation-specific affinity purification methods for plasma vitamin K-dependent proteins. J. Mol. Recognit. 9, 211–218 (1996).

    Article  CAS  Google Scholar 

  42. Savi, P. et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett. 422, 291–295 (1998).

    Article  CAS  Google Scholar 

  43. Graham, D.K., Dawson, T.L., Mullaney, D.L., Snodgrass, H.R. & Earp, H.S. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth. Differ. 5, 647–657 (1994).

    CAS  PubMed  Google Scholar 

  44. Roth, J. Postembedding labeling on Lowicryl K4M tissue sections: detection and modification of cellular components. Methods Cell. Biol. 31, 513–551 (1989).

    Article  CAS  Google Scholar 

  45. Lupu, F. et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler. Thromb. 13, 1090–1100 (1993).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank K. Bijnens, A. Bouché, I. Cartois, E. Demarsin, M. De Mol, K. Deroover, E. Gils, B. Hermans, S. Jansen, L. Kieckens, T. Vancoetsem, A. Vandenhoeck, I. Vanlinthout, M. Vanrusselt, P. Vanwesemael, I. Vreys and S. Wyns for technical assistance and J. Vermylen for critical reading of the manuscript. This work was supported by Sanofi Research and the Swedish Medical Research Council (Grants 07143, 12561 and 13000) and a Senior Investigators Award from the Swedish Foundation for Strategic Research. A. Angelillo-Scherrer is a recipient of awards from the Swiss National Foundation for Scientific Research and the Fondation Suisse pour les Bourses en Médecine et Biologie.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Carmeliet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angelillo-Scherrer, A., de Frutos, P., Aparicio, C. et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 7, 215–221 (2001). https://doi.org/10.1038/84667

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/84667

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing